A world-first clinical trial has demonstrated that cholesterol-lowering statins can safely reduce the risk of heart attacks and strokes by 30% in healthy people over 70.
The findings, presented at the ESC 2026 conference, suggest that statin therapy could be a vital tool in managing cardiovascular health for the aging population.
Doctors are now evaluating how these results might change standard clinical guidelines for prescribing preventative medication to older patients.